20 results
8-K
EX-99.1
HUMA
Humacyte Inc
10 May 24
Humacyte First Quarter 2024 Financial Results and Business Update
7:06am
of the webinar is available here https://lifescievents.com/event/humacyte-2/). In the study women, particularly obese and diabetic women, were observed
8-K
EX-99.1
HUMA
Humacyte Inc
29 Feb 24
Other Events
4:02pm
vein harvest in diabetics, women, and the overweight Durable and highly uniform in diameter and quality Potentially Transforming CABG Care: Greater … % develop infection 23% have persistent swelling; worse in obese and diabetic patients; 2x worse in women SVGs do not last long enough: ~33% of patients
DEF 14A
5l0zhmemi3mdpnlyuhu9
29 Apr 22
Definitive proxy
6:41am
424B7
df8jq zg8szgsm
4 Apr 22
Prospectus with selling stockholder info
5:22pm
POS AM
x636n
30 Mar 22
Prospectus update (post-effective amendment)
5:07pm
8-K
EX-99.1
a5w2y3
10 Jan 22
Regulation FD Disclosure
4:05pm
424B7
ixpbtrs1
10 Dec 21
Prospectus with selling stockholder info
12:00am
POS AM
rhl10p cj0i35oy3fmzd
19 Nov 21
Prospectus update (post-effective amendment)
5:26pm
424B7
gbw0w1xfri3
27 Oct 21
Prospectus with selling stockholder info
2:42pm
8-K
EX-99.3
8r7j6muj
27 Aug 21
Report of Independent Registered Public Accounting Firm
9:01pm
8-K
EX-99.2
hpq n1at27i1iv
7 Jun 21
Humacyte to Provide Investor Update on June 7
5:29pm
425
EX-99.2
geam3i
7 Jun 21
Business combination disclosure
5:27pm
8-K
EX-99.2
gzm5h8syjat0zf 7z
17 Feb 21
Entry into a Material Definitive Agreement
8:45am
425
EX-99.2
xchn2cqqur3i39i0rs2b
17 Feb 21
Business combination disclosure
8:43am
- Prev
- 1
- Next